Long-term treatment with anagliptin for 47 weeks reduced the number of liver tumors and tumor size in MC4R-KO mice, whereas there was no apparent difference in the number of foci between the treatments (Fig. 7b–d). This evidence concerns the gene MC4R and neoplasm.